CD274 and cancer: By elucidating the nexus between energy metabolism and immune function, we propose that targeted manipulation of both glycolytic pathways and the PD-1/PD-L1 axis could enhance anti-tumor immune responses, offering new therapeutic strategies for cancer treatment.